[PRESENTATION] Advances in Preclinical Models for Angiogenesis and wet AMD

Authors' picture

By Experimentica on April 7, 2022

Summary: Dr. Simon Kaja will present at the Wet AMD & DME Drug Development Summit 2022


Experimentica’s CSO and VP, Americas Dr. Simon Kaja will give a presentation about relevant preclinical animal models available to support drug development in wet AMD and diabetic macular edema at the Wet AMD & DME Drug Development Summit

Specifically, Dr. Kaja will present:

  • Preclinical models for angiogenesis and wet AMD
  • The utility of in vivo imaging in the standardized assessment of AMD phenotypes in preclinical models for angiogenesis and wet AMD
  • Our advances in AI and machine learning for the unbiased analysis of data from preclinical studies

The conference offers comprehensive insight into the current and emerging angiogenesis- inflammatory-directed and anti-fibrotic drug development programs for these three ophthalmic conditions – neovascular age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and diabetic macular edema (DME).

Experimentica is proud to sponsor this year’s edition of the Summit. Full program available here.

Authors' picture